What is BPC-157 used for?

BPC-157 is a synthetic peptide compound studied in laboratory research settings. Scientific literature has explored its properties in preclinical studies. It is not approved for human consumption.

What purity level does Onward Aminos's BPC-157 have?

Onward Aminos supplies BPC-157 at ≥99% purity, verified by third-party HPLC and mass spectrometry analysis. Certificates of Analysis are available upon request.

How is BPC-157 supplied?

BPC-157 is supplied as a lyophilized powder in sealed research-grade vials, intended for in vitro and laboratory research use only.

FREE SHIPPING THRESHOLD$250 REMAINING

SYSTEM: ACTIVE·INVENTORY // PEPTIDES·ITEM: BPC-157

MK-IV SPEC BPC-157

LAT: 34.0522° NLONG: 118.2437° W

RESEARCH ONLYOA-909-BPC157

BPC-157

Name: BPC-157
Brand: Onward Aminos
SKU: OA-BPC157

Cytoprotective Peptide

UNIT COST$29.00

STATUSIN STOCK

SELECT MASS (MG)

QTY

MISSION CRITICAL: For in vitro laboratory research only. Not for human or veterinary use. Not evaluated by the FDA. Must be 21+.

SPECIFICATIONS

CAS No.137525-51-0

Mol. Weight1419.56 g/mol

Purity≥99.0% (HPLC)

FormLyophilized Powder

Storage−20°C · Lyophilized

Mol. FormulaC₆₂H₉₈N₁₆O₂₂

COMPOUND INTEL

REF #OA-909-BPC157

MECHANISM_DUMP

MOLECULAR PROFILE

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a partial sequence of human gastric juice protein. With the molecular formula C₆₂H₉₈N₁₆O₂₂ and a molecular weight of 1419.53 g/mol (CAS: 137525-51-0), BPC-157 consists of 15 amino acids. Published research has characterized its interactions with the nitric oxide system, GABAergic pathways, and dopaminergic systems in preclinical tissue models.

AMINO ACID SEQUENCEGly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val

Cytoprotective PeptideNitric Oxide SystemGABAergic PathwaysDopaminergic Systems

MECHANISM OF ACTION

Nitric Oxide PathwayeNOS/NOS modulation

BPC-157 modulates nitric oxide synthase expression and activity, affecting vascular tone and tissue perfusion in preclinical models (PMID: 35489163).

Growth Factor SignalingVEGF/FGF pathways

Published research indicates interactions with vascular endothelial growth factor and fibroblast growth factor signaling cascades in tissue culture studies (PMID: 30915550).

Neurotransmitter SystemsDopamine/GABA modulation

BPC-157 has been shown to influence dopaminergic and GABAergic neurotransmission in neuronal cell culture models (PMID: 26809810).

TECHNICAL DATA

CAS No.: 137525-51-0
Mol. Formula: C₆₂H₉₈N₁₆O₂₂
Mol. Weight: 1419.56 g/mol
Purity: ≥99.0% (HPLC)
Form: Lyophilized Powder
Storage: −20°C · Lyophilized

PMID REFERENCE LIBRARY

PMID: 35489163

Sikiric et al. (2022) investigated BPC-157's interactions with growth factor and cytokine signaling pathways in gastric tissue models (PMID: 35489163).

Sikiric P, et al. (2022). BPC-157 and its healing effects. Front Pharmacol.PMID: 30915550

Seiwerth et al. (2019) examined BPC-157's molecular structure and receptor binding characteristics in endothelial cell cultures (PMID: 30915550).

Seiwerth S, et al. (2019). BPC 157: molecular mechanisms and therapeutic implications. Curr Pharm Des.PMID: 26809810

Sikiric et al. (2016) characterized the amino acid sequence and cytoprotective mechanisms in epithelial cell models (PMID: 26809810).

Sikiric P, et al. (2016). Novel cytoprotective mediator, stable gastric pentadecapeptide BPC 157. Regul Pept.PMID: 32786122

Duzel et al. (2020) analyzed BPC-157's effects on fibroblast proliferation and extracellular matrix components in vitro (PMID: 32786122).

Duzel A, et al. (2020). BPC 157 and tissue repair mechanisms. Biomedicines.